Related Experiment Video
Updated: Jul 6, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Cardiovascular regenerative medicine: digging in for the long haul
Jason C Kovacic1, Richard P Harvey, Stefanie Dimmeler
1Cardiology Branch, Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. kovacicj@mail.nih.gov
Insights
Cardiovascular cell-based regenerative medicine is rapidly evolving, challenging existing paradigms. Researchers are committed to the long-term effort required for significant advancements in this field.
Area of Science:
- Cardiovascular regenerative medicine
- Cell-based therapies
- Cardiac repair
Background:
- The field of cardiovascular cell-based regenerative medicine has progressed rapidly over the past decade.
- Numerous hypotheses have been proposed and tested, leading to a re-evaluation of established cardiovascular concepts.
Framework:
- The second Symposium on Cardiovascular Regenerative Medicine convened to discuss progress and challenges.
- Key issues included the critical reconsideration of long-held cardiovascular paradigms.
- The symposium highlighted both achievements and the substantial work remaining in the field.
Implementation:
- Showcasing highlights from the past decade of research.
- Addressing the complexities and challenges in translating cell-based therapies.
- Fostering discussion on future directions and research priorities.
Implications:
- Significant reconsideration of fundamental cardiovascular principles is underway.
- The field requires a sustained, long-term research commitment.
- Future progress necessitates a deep understanding of the challenges and a dedicated approach to overcoming them.
Abstract:
Cardiovascular cell-based regenerative medicine has enjoyed a brief but exciting history. In little over a decade, multiple hypotheses have risen and fallen, and this work has now triggered a critical reconsideration of several long-held cardiovascular paradigms. These and other issues were the focus of the second Symposium on Cardiovascular Regenerative Medicine, recently held at the NIH-NHLBI in Bethesda, MD, USA. The meeting served to showcase some of the highlights of the past decade but, at the same time, sharply underlined the enormity of the task ahead. Collectively, a sense emerged that researchers in this field are "digging in for the long haul."
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Whole Body Regeneration
Cardiomyopathy V: Interprofessional Care
Tissue Renewal without Stem Cells
However, failure of such a system...
Cardiomyopathy II: Dilated Cardiomyopathy

